the goal of the current study was to establish a quality control procedure for clinical use of 6- [ 18f ] fluoro-l-dopa ( 6- [ 18f ] -dopa ) as a selective presynaptic positron emission tomographic ( pet ) imaging ligand for brain dopamine neurons .
C0023570
l-dopa
C0013023
dopa